Earn the UPMC LGBTQIA+ Affirming Provider designation!
Sep. 2022Important Notices
"UPMC Health Plan has established the LGBTQIA+ Affirming Provider designation to make it easy for members to find providers who can communicate and validate LGBTQIA+ patient experiences and create a safe and welcoming patient-provider relationship for LGBTQIA+ patients. This designation is an indicator of a provider’s cultural competency.
To be eligible for the LGBTQIA+ Affirming Provider designation, providers must be listed in either the UPMC Health Plan Find Care provider directory or the UPMC Health Services Find a Doctor provider directory.
The designation will be visible to patients and members in the directories this summer or fall.
Providers can earn the LGBTQIA+ Affirming Provider designation now by completing three learning modules and an attestation. Each learning module is approved for a maximum of 1.0 AMA PRA Category 1 Credits™.
Non-UPMC employed providers can access the learning modules and attestation on UPMC Health Plan’s patient health resources page.
UPMC-employed providers can access the learning modules and attestation through HR Direct Learning by searching for ""Affirmative Communication with LGBTQIA+ Patients & Members."""
To be eligible for the LGBTQIA+ Affirming Provider designation, providers must be listed in either the UPMC Health Plan Find Care provider directory or the UPMC Health Services Find a Doctor provider directory.
The designation will be visible to patients and members in the directories this summer or fall.
Providers can earn the LGBTQIA+ Affirming Provider designation now by completing three learning modules and an attestation. Each learning module is approved for a maximum of 1.0 AMA PRA Category 1 Credits™.
Non-UPMC employed providers can access the learning modules and attestation on UPMC Health Plan’s patient health resources page.
UPMC-employed providers can access the learning modules and attestation through HR Direct Learning by searching for ""Affirmative Communication with LGBTQIA+ Patients & Members."""
Recent Announcements
Voluntary nationwide recall: Famotidine (Fresenius – November)
Fresenius Kabi USA, LLC is recalling three lots (6133156, 6133194, and 6133388) of Famotidine Injection, USP, 20 mg per 2 mL. Famotidine is used to treat excessive secretion of stomach acid or stomach ulcers.Nov. 2025Pharmacy Updates
Medicaid provider update: High-cost Medicaid drug billing
Billing requirements for Medicaid-covered drugsNov. 2025Important Notices
Training Webinar: Conversio Health COPD Management Program
Please join us for a live training webinar for primary care providers and pulmonologists by UPMC Health Plan that will provide an overview of a comprehensive COPD management program from Conversio Health.Nov. 2025Education/Webinars